Adler, G., Mueller, B., & Articus, K. (2014). The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions. Int J Clin Pract.
Chicago Style aipamenaAdler, G., B. Mueller, and K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
MLA aipamenaAdler, G., B. Mueller, and K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.